| 7.15 Data as of May 21 | +0.07 / +0.99%Today’s Change | 5.51 Today|||52-Week Range 17.20 | +4.75% Year-to-Date |
| SECTOR Technology Services | INDUSTRY Information Technology Services | MARKET CAP $5.8M |
Company Description
Spherix, Inc. is a scientific research company. The company provides services through its subsidiaries. It operates its business through two segments: Biospherics and Health Sciences. The Biospherics is engaged in a Phase 3 clinical trial to study the use of D-tagatose as a treatment for Type 2 diabetes. The Health Sciences segment provides technical and regulatory consulting services to biotechnology and pharmaceutical companies, as well as providing technical support for its R&D activities. The company was founded by Gilbert V. Levin & Karen M. Levin in 1967 and is headquartered in Bethesda, MD.
Employees

Shareholders
| Individual stakeholders | 16.20% |
| Other institutional | 0.25% |
| Mutual fund holders | 0.18% |
Top Executives
| Harvey J. Kesner, MBA | Chief Executive Officer & Director |
| Robert A. Lodder, Jr., PhD | President & Head-Investor Relations |
| Claire L. Kruger, PhD | Chief Operating Officer |
| Robert L. Clayton, CPA | Chief Financial Officer, Secretary & Treasurer |
| Katherine M. Brailer | Director-Administrative Services |